Overview
Tak Mak practices in Hong Kong, China. Mak is highly rated in 5 conditions, according to our data. Their top areas of expertise are Angioimmunoblastic T-cell Lymphoma, Lymphofollicular Hyperplasia, Breast Cancer, and CACH Syndrome.
Their clinical research consists of co-authoring 505 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Angioimmunoblastic T-cell Lymphoma
- Breast CancerMak isAdvanced. Learn about Breast Cancer.
- CACH SyndromeMak isAdvanced. Learn about CACH Syndrome.
- Lymphofollicular Hyperplasia
- MeningitisMak isAdvanced. Learn about Meningitis.
- Experienced
- AchondrogenesisMak isExperienced. Learn about Achondrogenesis.
- Acrokeratoelastoidosis of Costa
- Acromesomelic DysplasiaMak isExperienced. Learn about Acromesomelic Dysplasia.
- Acromesomelic Dysplasia Campailla Martinelli Type
- Acromesomelic Dysplasia Hunter Thompson Type
- Acromesomelic Dysplasia Maroteaux Type